The 2019 Position Statement on the use of Tomosynthesis within BreastScreen Australia
The Commonwealth Department of Health commissioned Allen and Clarke Policy and Regulatory Specialists to prepare a Position Statement on the use of Tomosynthesis within BreastScreen Australia. The 2019 Position Statement was endorsed by the Australian Health Ministers’ Advisory Committee (AHMAC) Standing Committee on Screening in 2019, and by the AHMAC Clinical Advisory Committee in 2020. The 2019 Position Statement replaces the 2014 Position Statement prepared by BreastScreen Australia, a joint Australian State and Territory Government Program.
The 2019 Position Statement has been endorsed by the following organisations:
- Australasian College of Physical Scientists and Engineers in Medicine
- Australian Society of Breast Physicians
- Australian Society of Medical Imaging and Radiation Therapy
- BreastSurg ANZ
- Breast Cancer Network Australia
- Cancer Australia
- Cancer Council Australia
- The AHMAC Clinical Principal Committee
- The AHMAC Standing Committee on Screening
- The 2019 Position Statement on the use of Tomosynthesis within BreastScreen Australia Services (PDF 880 KB)
- The 2019 Position Statement on the use of Tomosynthesis within BreastScreen Australia Services (Word 57 KB)
The 2014 Position Statement on the use of Tomosynthesis within BreastScreen Australia
In 2014, BreastScreen Australia prepared a Position Statement on the use of tomosynthesis (3D mammography) within BreastScreen Australia. This document has been superceded and is provided for research and reference purposes only.
- The 2014 Position Statement on the use of Tomosynthesis within BreastScreen Australia Services (PDF 406 KB)
- The 2014 Position Statement on the use of Tomosynthesis within BreastScreen Australia Services (Word 77 KB)